Real-World (RW) Comparative Effectiveness of Covalent Bruton Tyrosine Kinase Inhibitors (cBTKis) Among Patients With Relapsed/Refractory Mantle Cell Lymphoma (R/R MCL)

Autor: Phillips, Tycel, Guinter, Mark A., Miller, Taavy A., Wang, Jingru, Pierre, Amy, Maglinte, Gregory A., Seymour, Erlene K.
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia September 2024 24 Supplement 1:S228-S228
Databáze: ScienceDirect